Home › Coronary Artery Disease › Nebraska
Coronary Artery Disease clinical trials in Nebraska
7 studies for Coronary Artery Disease are looking for participants at sites in Nebraska.
Cities in Nebraska
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
- CHI Health Nebraska Heart, Grand Island
- Bryan Heart, Lincoln
- CHI Health Nebraska Heart, Lincoln
- and 1 more
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06909565Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- GSR Enterprises, Inc., Lincoln
- Great Plains Health - Nephrology, North Platte
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05485961Product Surveillance Registry
- Omaha
RecruitingObservational study
All ages · All sexes · Updated Sep 18, 2026 · NCT01524276Randomization of Single vs Multiple Arterial Grafts
- Nebraska Heart Hospital, Lincoln
- University of Nebraska Medical Center, Omaha
Recruiting
Ages 18 to 70 · All sexes · Updated Aug 20, 2026 · NCT03217006Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
- Nebraska Heart Hospital, Lincoln
- Methodist Physicians Health, Omaha
- University of Nebraska Medical Center, Omaha
Recruiting
Ages 18 and older · Women · Updated Apr 1, 2026 · NCT04124120Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
- Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE, Omaha
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Dec 17, 2025 · NCT02915198Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement
- Bryan Heart, Lincoln
Recruiting
All ages · All sexes · Updated Jul 24, 2025 · NCT04634240From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.